{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:36Z","timestamp":1786982676147,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Arcutis Biotherapeutics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s13555-024-01190-4","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T06:01:55Z","timestamp":1718344915000},"page":"1839-1847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States"],"prefix":"10.1007","volume":"14","author":[{"given":"Teri","family":"Greiling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melodie","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa S.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Higham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"1190_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323:1945\u201360. https:\/\/doi.org\/10.1001\/jama.2020.4006.","journal-title":"JAMA"},{"key":"1190_CR2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the United States. JAMA Dermatol. 2021;157:940\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2021.2007.","journal-title":"JAMA Dermatol"},{"key":"1190_CR3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5114\/reum.2018.80718","volume":"56","author":"K Dopytalska","year":"2018","unstructured":"Dopytalska K, Sobolewski P, B\u0142aszczak A, Szyma\u0144ska E, Walecka I. Psoriasis in special localizations. Reumatologia. 2018;56:392\u20138. https:\/\/doi.org\/10.5114\/reum.2018.80718.","journal-title":"Reumatologia"},{"key":"1190_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","volume":"84","author":"CA Elmets","year":"2021","unstructured":"Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021;84:432\u201370. https:\/\/doi.org\/10.1016\/j.jaad.2020.07.087.","journal-title":"J Am Acad Dermatol"},{"key":"1190_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","volume":"60","author":"RE Kalb","year":"2009","unstructured":"Kalb RE, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2009;60:824\u201337. https:\/\/doi.org\/10.1016\/j.jaad.2008.11.906.","journal-title":"J Am Acad Dermatol"},{"key":"1190_CR6","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/jdv.15065","volume":"32","author":"A Armstrong","year":"2018","unstructured":"Armstrong A, Jarvis S, Boehncke WH, et al. Patient perceptions of clear\/almost clear skin in moderate-to-severe plaque psoriasis: results of the clear about psoriasis worldwide survey. J Eur Acad Dermatol Venereol. 2018;32:2200\u20137. https:\/\/doi.org\/10.1111\/jdv.15065.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1190_CR7","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/jid.2013.508","volume":"134","author":"EA Dowlatshahi","year":"2014","unstructured":"Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol. 2014;134:1542\u201351. https:\/\/doi.org\/10.1038\/jid.2013.508.","journal-title":"J Invest Dermatol"},{"key":"1190_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/09546634.2015.1044492","volume":"27","author":"D Pariser","year":"2016","unstructured":"Pariser D, Schenkel B, Carter C, Farahi K, Brown TM, Ellis CN. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis. J Dermatolog Treat. 2016;27:19\u201326. https:\/\/doi.org\/10.3109\/09546634.2015.1044492.","journal-title":"J Dermatolog Treat"},{"key":"1190_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052935","volume":"7","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003\u20132011. PLoS ONE. 2012;7:e52935. https:\/\/doi.org\/10.1371\/journal.pone.0052935.","journal-title":"PLoS ONE"},{"key":"1190_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/bjd.17147","volume":"180","author":"M Larsabal","year":"2019","unstructured":"Larsabal M, Ly S, Sbidian E, et al. GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis. Br J Dermatol. 2019;180:647\u201356. https:\/\/doi.org\/10.1111\/bjd.17147.","journal-title":"Br J Dermatol"},{"key":"1190_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jaad.2013.12.018","volume":"70","author":"MG Lebwohl","year":"2014","unstructured":"Lebwohl MG, Bachelez H, Barker J, et al. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 2014;70:871-81.e1-30. https:\/\/doi.org\/10.1016\/j.jaad.2013.12.018.","journal-title":"J Am Acad Dermatol"},{"key":"1190_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.5603\/gp.2016.0074","volume":"87","author":"P Czuczwar","year":"2016","unstructured":"Czuczwar P, St\u0119pniak A, Goren A, et al. Genital psoriasis: a hidden multidisciplinary problem\u2014a review of literature. Ginekol Pol. 2016;87:717\u201321. https:\/\/doi.org\/10.5603\/gp.2016.0074.","journal-title":"Ginekol Pol"},{"key":"1190_CR13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jaad.2019.10.077","volume":"82","author":"MM Mauskar","year":"2020","unstructured":"Mauskar MM, Marathe K, Venkatesan A, Schlosser BJ, Edwards L. Vulvar diseases: conditions in adults and children. J Am Acad Dermatol. 2020;82:1287\u201398. https:\/\/doi.org\/10.1016\/j.jaad.2019.10.077.","journal-title":"J Am Acad Dermatol"},{"key":"1190_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1067\/mjd.2001.117046","volume":"45","author":"M Lebwohl","year":"2001","unstructured":"Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol. 2001;45:487\u2013502. https:\/\/doi.org\/10.1067\/mjd.2001.117046.","journal-title":"J Am Acad Dermatol"},{"key":"1190_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/bjd.13065","volume":"171","author":"B Zhu","year":"2014","unstructured":"Zhu B, Edson-Heredia E, Guo J, Maeda-Chubachi T, Shen W, Kimball AB. Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial. Br J Dermatol. 2014;171:1215\u20139. https:\/\/doi.org\/10.1111\/bjd.13065.","journal-title":"Br J Dermatol"},{"key":"1190_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/bjd.16332","volume":"179","author":"CEM Griffiths","year":"2018","unstructured":"Griffiths CEM, Jo S-J, Naldi L, et al. A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey. Br J Dermatol. 2018;179:173\u201381. https:\/\/doi.org\/10.1111\/bjd.16332.","journal-title":"Br J Dermatol"},{"key":"1190_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s13555-017-0204-3","volume":"7","author":"JC Cather","year":"2017","unstructured":"Cather JC, Ryan C, Meeuwis K, et al. Patients\u2019 perspectives on the impact of genital psoriasis: a qualitative study. Dermatol Ther (Heidelb). 2017;7:447\u201361. https:\/\/doi.org\/10.1007\/s13555-017-0204-3.","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01190-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01190-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01190-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T13:17:06Z","timestamp":1721481426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01190-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01190-4","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Teri Greiling has received investigator fees, speaker fees, clinical research grants, and\/or honoraria from Arcutis Biotherapeutics, Inc. Melodie Young has received investigator fees, speaker fees, clinical research grants, and\/or honoraria from AbbVie, Arcutis Biotherapeutics, Inc., Celgene Corporation, Eli Lilly, Janssen, Merck\/Sun, Novartis, and UCB. April Armstrong has served as a research investigator, scientific adviser, or speaker to AbbVie, Almirall, Arcutis, ASLAN, Beiersdorf, BI, BMS, EPI, Incyte, Leo, UCB, Janssen, Lilly, Mindera, Nimbus, Novartis, Ortho Dermatologics, Sun, Dermavant, Dermira, Sanofi, Regeneron, and Pfizer. Melissa S. Seal and Robert C. Higham are employees of Arcutis Biotherapeutics, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The trial was conducted in accordance with the principles of the Declaration of Helsinki of 1964 and its later amendments and Good Clinical Practice guidelines of the International Council for Harmonisation. Before enrollment of patients, the study protocol and informed consent form were reviewed and approved by an appropriate institutional review board or independent ethics committee. Participants provided consent to participate in the survey and to report data in aggregate, not individual participant data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}